Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Deutenzalutamide (enzalutamide-d3) | 1443331-82-5 | 99.8% | C21H13D3F4N4O2S | 1 MG
Supplier: Medchemexpress LLC HY70002S1MG
Deutenzalutamide (Enzalutamide-d3) is a deuterium-labeled form of Enzalutamide, an androgen receptor (AR) antagonist. It serves as a tracer and internal standard for quantitative analysis methods including NMR, GC-MS, or LC-MS. Deuterated compounds offer advantages such as extending in vivo half-life, improving oral bioavailability, and enhancing metabolic characteristics for drug safety.
- Androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells
- Functions as a tracer for quantitative analysis
- Serves as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Deuteration may extend in vivo half-life, improve oral bioavailability, and enhance metabolic characteristics
- Potential to improve drug safety while retaining therapeutic properties
- Utilized in cancer, cancer targeted therapy, and cancer metabolism research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?